This Is MS Multiple Sclerosis Community: Knowledge & Support

Welcome to the world's leading forum on Multiple Sclerosis research, support, and knowledge. For over 10 years, This is MS has provided an unbiased community dedicated to Multiple Sclerosis patients, caregivers, and affected loved ones.
It is currently Sat May 25, 2013 4:17 pm


All times are UTC - 8 hours [ DST ]




Post new topic Reply to topic  [ 1 post ] 
Author Message
PostPosted: Fri Jul 27, 2007 7:52 am 
Offline
Family Elder
User avatar

Joined: Wed Aug 11, 2004 3:00 pm
Posts: 1610
I didn't think the first clinical trial results on mesenchymal stem cell therapy would come from Iran, but I'm glad they are pushing MS research along.



Does mesenchymal stem cell therapy help multiple sclerosis patients? Report of a pilot study.

Iran J Immunol. 2007 Mar;4(1):50-7.
Mohyeddin Bonab M, Yazdanbakhsh S, Lotfi J, Alimoghaddom K, Talebian F, Hooshmand F, Ghavamzadeh A, Nikbin B.
Hematology-Oncology & BMT Research Center, Tehran, Iran.

BACKGROUND: Mesenchymal stem cells (MSCs) with their potential to differentiate into mesodermal and non-mesodermal lineages have several immunomodulatory characteristics. These properties make them promising tools in cell and gene therapy.

OBJECTIVE: To evaluate the potential therapeutic applications of autologous MSC in improving clinical manifestations of MS patients.

METHODS: Ten patients were included in this pilot study. All had progressive disease that had not responded to disease modifying agents including Mitoxantrone. Their Expanded Disability Status Scale (EDSS) score ranged from 3.5 to 6. Patients were injected intrathecally with culture expanded MSCs. They were followed with monthly neurological assessment and a MRI scan at the end of the first year.

RESULTS: During 13 to 26 months of follow up (mean: 19 months), the EDSS of one patient improved from 5 to 2.5 score. Four patients showed no change in EDSS. Five patients' EDSS increased from 0.5 to 2.5. In the functional system assessment, six patients showed some degree of improvement in their sensory, pyramidal, and cerebellar functions. One showed no difference in clinical assessment and three deteriorated. The result of MRI assessment after 12 months was as following: seven patients with no difference, two showed an extra plaque, and one patient showed decrease in the number of plaques.

CONCLUSION: This preliminary report emphasizes on the feasibility of autologous MSC for treatment of MS patients. However, in order to draw a definitive conclusion a larger sample size is required.

Pubmed link


Top
 Profile  
 
Display posts from previous:  Sort by  
Post new topic Reply to topic  [ 1 post ] 

All times are UTC - 8 hours [ DST ]


Related topics
 Topics   Author   Replies   Views   Last post 
There are no new unread posts for this topic. Completed mesenchymal stem cell trial

Frank

0

1701

Mon Nov 26, 2007 5:39 am

Frank View the latest post

There are no new unread posts for this topic. Another stem cell trial

dignan

0

1647

Sun Nov 18, 2007 2:54 pm

dignan View the latest post

There are no new unread posts for this topic. UK stem cell early trial for MS

bromley

5

2292

Fri Sep 21, 2007 8:50 am

retired_at_40_01 View the latest post

There are no new unread posts for this topic. Stem cell trial:Prof Scolding

Jaded

0

1452

Sun Sep 30, 2007 1:53 pm

Jaded View the latest post

There are no new unread posts for this topic. Prof Scolding stem cell trial

bromley

1

1450

Thu Dec 11, 2008 8:37 am

Jaded View the latest post

 


Who is online

Users browsing this forum: No registered users


You cannot post new topics in this forum
You cannot reply to topics in this forum
You cannot edit your posts in this forum
You cannot delete your posts in this forum

Search for:
Jump to: